Regulatory
FDA Clears a New Alzheimer’s Blood Test for Adults With Symptoms as Young as 40
C2N Diagnostics’ PrecivityAD2 measures amyloid and tau markers from a blood draw — part of a fast-moving shift away from expensive scans and spinal taps for Alzheimer’s diagnosis.